Relationships mean platelet volume dengan miocardial quantitative blush-est ima patients undergoing primary percutaneous coronary intervention

  • Sri Murdiati Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia and National Cardiovascular Center Harapan Kita, Jakarta
  • Yoga Yuniadi Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia and National Cardiovascular Center Harapan Kita, Jakarta

Abstract

Background. Mean platelet volume is a marker of platelet, size and activation functions. Increased mean platelet volume showed a large and active platelet release more thromboxane A2 than smaller ones. A simple marker was detected using a fast and functional techniques will help approaches to inflammation caused by platelets. Thus MPV is an important examination of effective simple, easy, and low cost to be used and explored extensively, particularly in developing countries such as Indonesia, to predict the likelihood of complications to come.
Methods and Results. Seventy-two patients (age minimum 30 years and maximum 80 years who came to the hospital with a presentation IMA-EST onset less than 12 hours were included in this study. Following primary percutaneous intervention coroner examined myocardial blush with Qube and see the relationship with the value mean platelet volume (MPV) in assessing myocardial flow. End point of this study is the lack of correlation between MPV values in the assessment of myocardial blush Qube post-reperfusion.
Conclusion. MPV values in this population as the initial entry no relationship with Qube in assessing the value of post-reperfusion myocardial blush

Downloads

Download data is not yet available.

References

R?dvan MDC, Dilek I, Asker M, Atmac M. Mean platelet volume in acute coronary syndrome. Van T?p Dergisi. 2010;17:89-95

Badan Penelitian dan Penegmbangan Kesehatan Kementrian Kesehatan Republik Indonesia. Laporan Nasional Riskesdas 2007. Diunduh dari http://www.litbang.depkes.go.id/bl_riskesdas2007

Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA et al. Esc guidelines for the management of acute myocardial infarction in patients presenting with st-segment elevation: The task force on the management of st-segment elevation acute myocardial infarction of the european society of cardiology (esc). European heart journal. 2012;33:2569-2619

Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H et al. Esc guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation: The task force for the management of acute coronary syndromes (acs) in patients presenting without persistent stsegment elevation of the european society of cardiology (esc). European heart journal. 2011;32:2999-3054

Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no reflow in human. J Am Coll Cardiol 2009; 54: 281-92

Kereiakes DJ, Gurbel PA. Peri-procedural platelet function and platelet inhibition in percutaneous coronary intervention. JACC. Cardiovascular interventions. 2008;1:111-121

Packard RR, Libby P. Inflammation in atherosclerosis: From vascular biology to biomarker discovery and risk prediction. Clinical chemistry. 2008;54:24-38

Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. The New England journal of medicine. 2005;352:1685-1695

Vogelzang M, Vlaar PJ, Svilaas T, Amo D, Nijsten MW, Zijlistra F. Computer-assisted myocardial blush quantification after percutaneous coronary angioplasty for acute myocardial infarction: a substudy from the TAPAS trial. Eur Heart J 2009;30:549-99

Maddahi J, Van Train K, Prigent F, Garcia EV, Friedman J, Ostrzega E, Berman D. Quantitative single photon emission computed thallium-201 tomography for detection and localization of coronary artery disease: Optimization and prospective validation of a new technique. Journal of the American College of Cardiology. 1989;14:1689-1699

Yasar SA, Bilen E, Yuksel OI, Arslantas U,karakas F.Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction. Arch turk Soc Cardiol. 2010;38 (2):85-89.

Kishk YT, Trowbridge EA, Martin JF. Platelet volume subpopulations in acute myocardial infarction: An investigation of their homogeneity for smoking, infarct size and site. Clin Sci (Lond). 1985;68:419-425

Trowbridge EA, Martin JF, Slater DN, Kishk YT, Warren CW, Harley PJ, Woodcock B. The origin of platelet count and volume. Clinical physics and physiological measurement : an official journal of the Hospital Physicists’ Association, Deutsche Gesellschaft fur Medizinische Physik and the European Federation of Organisations for Medical Physics. 1984;5:145-170

Berger JS, Eraso LH, Xie D, Sha D, Mohler ER, 3rd. Mean platelet volume and prevalence of peripheral artery disease, the national health and nutrition examination survey, 1999-2004. Atherosclerosis. 2010;213:586-591

Arslan N, Makay B. Mean platelet volume in obese adolescents with nonalcoholic fatty liver disease. Journal of pediatric endocrinology & metabolism : JPEM. 2010;23:807-813

Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: A systematic review and meta-analysis. Journal of thrombosis and haemostasis : JTH. 2010;8:148-156

Furie B, Furie BC. Mechanisms of thrombus formation. The New England journal of medicine. 2008;359:938-949

Kristensen SD, Roberts KM, Kishk YT, Martin JF. Accelerated atherogenesis occurs following platelet destruction and increases in megakaryocyte size and DNA content. European journal of clinical investigation. 1990;20:239-247

Kishk YT, Trowbridge EA, Martin JF. The effects of exercise on platelet numbers and size. Medical laboratory sciences. 1985;42:406-408

Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomen-clature. Circulation. 1979;59:607-609.

Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991;338:1409-11

Vakili H, Kowssari R, Namazi M,s Motamedi RM, Sadat H et al. Could mean Platelet Volume Predict Impaired Reperfusion and In-Hospital Major Adverse Cardiovascular Event in Patients with Primary Percutaneous Coronary Intervention after ST-Elevation MyocardialInfarction. J the U Heart Ctr 1. 2009; 17-23.

Kiliçli-Camur N, Demirtunç R, Konuralp C, Eskiser A, Baºaran Y. Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sci Monit 2005;11:387-92.

Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002;117:399-404.
Published
2014-03-03
Views & Downloads
Abstract views: 2994   
PDF downloads: 2091   
How to Cite
Murdiati, S., & Yuniadi, Y. (2014). Relationships mean platelet volume dengan miocardial quantitative blush-est ima patients undergoing primary percutaneous coronary intervention. Indonesian Journal of Cardiology, 34(2), 92-7. https://doi.org/10.30701/ijc.v34i2.326
Section
Clinical Research